Parsons, H. A., & Burstein, H. J. (2021). Adjuvant Capecitabine in Triple-Negative Breast Cancer: New Strategies for Tailoring Treatment Recommendations. JAMA: Journal of the American Medical Association, 325(1), 36. https://doi.org/10.1001/jama.2020.23371
Chicago Style (17th ed.) CitationParsons, Heather A., and Harold J. Burstein. "Adjuvant Capecitabine in Triple-Negative Breast Cancer: New Strategies for Tailoring Treatment Recommendations." JAMA: Journal of the American Medical Association 325, no. 1 (2021): 36. https://doi.org/10.1001/jama.2020.23371.
MLA (9th ed.) CitationParsons, Heather A., and Harold J. Burstein. "Adjuvant Capecitabine in Triple-Negative Breast Cancer: New Strategies for Tailoring Treatment Recommendations." JAMA: Journal of the American Medical Association, vol. 325, no. 1, 2021, p. 36, https://doi.org/10.1001/jama.2020.23371.